Table 3.
Meta-analysis results of the association between SNPs in UGT1A1/UGT2B7 and AT-DILI risk under different genetic models.
| Genes | Country | SNPs | Study numbers | Dominant model | Recessive model | Homozygote model | Heterozygote model | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heterogeneity test | Overall effect | Heterogeneity test | Overall effect | Heterogeneity test | Overall effect | Heterogeneity test | Overall effect | ||||||||||||||||
| χ 2 | P | I 2 | OR (95% CI) | P | χ 2 | P | I 2 | OR (95% CI) | P | χ 2 | P | I 2 | OR (95% CI) | P | χ 2 | P | I 2 | OR (95% CI) | P | ||||
| UGT1A1 | All | rs4148323 (G> A) | 5 | 4.24 | 0.374 | 6 | 0.989 (0.824–1.188) | 0.909 | 5.55 | 0.238 | 28 | 0.775 (0.432–1.391) | 0.393 | 5.97 | 0.204 | 33 | 0.780 (0.419–1.452) | 0.433 | 3.03 | 0.552 | 0 | 1.017 (0.851–1.216) | 0.852 |
| All | rs2003569 (G> A) | 2 | 0.00 | 1.000 | 0 | 0.970 (0.740–1.272) | 0.824 | 0.01 | 0.929 | 0 | 1.090 (0.574–2.070) | 0.793 | 0.01 | 0.927 | 0 | 1.075 (0.562–2.054) | 0.828 | 0.00 | 0.994 | 0 | 0.956 (0.720–1.269) | 0.756 | |
| All | rs8330 (C > G) | 2 | 0.71 | 0.399 | 0 | 0.827 (0.634–1.079) | 0.161 | 0.06 | 0.813 | 0 | 0.908 (0.553–1.491) | 0.730 | 0.00 | 0.956 | 0 | 0.824 (0.499–1.361) | 0.450 | 0.90 | 0.342 | 0 | 0.825 (0.617–1.104) | 0.196 | |
| All | rs4148328 (T > C) | 2 | 4.47 | 0.034 | 78 | 0.970 (0.638–1.476) | 0.887 | 3.15 | 0.076 | 68 | 1.025 (0.634–1.658) | 0.918 | 5.23 | 0.022 | 81 | 1.003 (0.509–1.973) | 0.994 | 2.69 | 0.101 | 63 | 0.966 (0.685–1.361) | 0.843 | |
| All | rs3755319 (A > C) | 2 | 0.36 | 0.551 | 0 | 1.258 (0.969–1.634) | 0.084 | 0.01 | 0.932 | 0 | 0.637 (0.404–1.002) | 0.051 | 0.02 | 0.882 | 0 | 0.737 (0.461–1.178) | 0.203 | 0.06 | 0.813 | 0 | 1.454 (1.100–1.921) | 0.009 | |
| China | rs4148323 (G> A) | 4 | 4.18 | 0.243 | 28 | 1.000 (0.791–1.265) | 0.998 | 4.72 | 0.196 | 36 | 0.704 (0.347–1.426) | 0.330 | 5.10 | 0.166 | 41 | 0.708 (0.333–1.505) | 0.370 | 3.03 | 0.387 | 1 | 1.017 (0.842–1.227) | 0.862 | |
|
| |||||||||||||||||||||||
| UGT2B7 | China | rs7662029 (A > G) | 2 | 0.06 | 0.813 | 0 | 2.371 (1.779–3.160) | <0.001 | 0.03 | 0.858 | 0 | 0.739 (0.444–1.231) | 0.246 | 0.01 | 0.938 | 0 | 1.219 (0.715–2.077) | 0.467 | 0.10 | 0.76 | 0 | 2.686 (1.988–3.627) | <0.001 |
| China | rs7439366 (T > C) | 2 | 0.35 | 0.554 | 0 | 0.347 (0.238–0.506) | <0.001 | 0.00 | 0.950 | 0 | 0.675 (0.507–0.898) | 0.007 | 0.11 | 0.739 | 0 | 0.338 (0.225–0.508) | <0.001 | 0.59 | 0.443 | 0 | 0.359 (0.238–0.540) | <0.001 | |
UGT1A1, UDP-glucuronosyltransferase 1A1; UGT2B7, UDP-glucuronosyltransferase 2B7; AT-DILI, antituberculosis drug-induced liver injury; SNPs, single nucleotide polymorphisms; OR, odds ratio; 95% CI, 95% confidence interval.